We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+2.32%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$487M
AUM Growth
-$3.73M
Cap. Flow
-$8.32M
Cap. Flow %
-1.71%
Top 10 Hldgs %
15.73%
Holding
436
New
2
Increased
1
Reduced
5
Closed
46

Top Buys

Rank Stock Value
1
CARM
Carisma Therapeutics
CARM
+$374K
2
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
+$177K
3
KMI icon
Kinder Morgan
KMI
+$34

Top Sells

Rank Stock Value
1
FRX
FOREST LABORATORIES INC
FRX
+$1.21M
2
CEC
CEC ENTERTAINMENT INC
CEC
+$1.11M
3
CMG icon
Chipotle Mexican Grill
CMG
+$1.1M
4
AAPL icon
Apple
AAPL
+$799K
5
CELG
Celgene Corp
CELG
+$792K

Sector Composition

Rank Sector Weight
1 Technology 15.19%
2 Financials 14.01%
3 Healthcare 13.17%
4 Industrials 11.79%
5 Energy 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XEL icon
301
Xcel Energy
XEL
$48.8B
$493K 0.1%
16,243
– –
FTD
302
DELISTED
FTD Companies, Inc. Common Stock
FTD
$477K 0.1%
15,000
– –
PIR
303
DELISTED
Pier 1 Imports, Inc.
PIR
$472K 0.1%
1,250
– –
URS
304
DELISTED
URS CORP
URS
$471K 0.1%
10,000
– –
EXXI
305
DELISTED
ENERGY XXI LTD COM SHS
EXXI
$471K 0.1%
20,000
– –
CROX icon
306
Crocs
CROX
$6.14B
$468K 0.1%
30,000
– –
FRX
307
DELISTED
FOREST LABORATORIES INC
FRX
$461K 0.09%
5,000
-15,000
-75% -$1.21M
BXP icon
308
Boston Properties
BXP
$11.2B
$458K 0.09%
4,000
– –
LGND icon
309
Ligand Pharmaceuticals
LGND
$5.76B
$448K 0.09%
10,686
– –
LM
310
DELISTED
Legg Mason, Inc.
LM
$441K 0.09%
9,000
– –
CPWR
311
DELISTED
COMPUWARE CORP
CPWR
$420K 0.09%
41,640
– –
SNPS icon
312
Synopsys
SNPS
$74.4B
$413K 0.08%
10,742
– –
DOV icon
313
Dover
DOV
$27.6B
$409K 0.08%
6,190
-1,269
-17% -$79K
CARM
314
DELISTED
Carisma Therapeutics
CARM
$406K 0.08%
+1,250
New +$374K
ARQL
315
DELISTED
Arqule Inc
ARQL
$390K 0.08%
190,000
– –
JNPR
316
DELISTED
Juniper Networks
JNPR
$386K 0.08%
15,000
– –
ABT icon
317
Abbott
ABT
$183B
$385K 0.08%
10,000
– –
C icon
318
Citigroup
C
$222B
$381K 0.08%
8,000
– –
PEG icon
319
Public Service Enterprise Group
PEG
$38.2B
$381K 0.08%
10,000
– –
MOH icon
320
Molina Healthcare
MOH
$10.2B
$376K 0.08%
10,000
– –
JNY
321
DELISTED
JONES GROUP INC COM STK (PA)
JNY
$374K 0.08%
25,000
– –
NKTR icon
322
Nektar Therapeutics
NKTR
$2.39B
$364K 0.07%
2,000
– –
CLNE icon
323
Clean Energy Fuels
CLNE
$427M
$358K 0.07%
40,000
– –
NI icon
324
NiSource
NI
$21.3B
$355K 0.07%
25,450
– –
LUV icon
325
Southwest Airlines
LUV
$22B
$354K 0.07%
15,000
– –
11 12
13
14 15

Similar funds

IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
BFS
Bard Financial Services Branford, Connecticut $911M AUM 19.14% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
CP
Coho Partners Berwyn, Pennsylvania $779M AUM 4.46% 1-Year Est. Return
EAM
EFG Asset Management Portland, Oregon $773M AUM 40.1% 1-Year Est. Return
HWM
Hemington Wealth Management Falls Church, Virginia $769M AUM 13.16% 1-Year Est. Return
BVDMP
Bedrijfstakpensioenfonds Voor De Media PNO Hilversum, Netherlands $759M AUM 19.37% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's Q1 2014 Portfolio in Review

As of Q1 2014, NJ State Employees Deferred Compensation Plan held 436 positions worth $487M, down 0.76% from $490M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

NJ State Employees Deferred Compensation Plan's Q1 2014 filing shows 2 new, 1 increased, 5 reduced and 46 closed positions. Its largest new stake was Carisma Therapeutics: 1,250 shares worth $406K. The largest sale was FOREST LABORATORIES INC, an estimated $1.21M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

  • NJ State Employees Deferred Compensation Plan's largest Q1 2014 buy was Carisma Therapeutics: 1,250 shares worth $406K.
  • NJ State Employees Deferred Compensation Plan added most to Kinder Morgan in Q1 2014, an estimated $34 increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q1 2014 reduction was FOREST LABORATORIES INC, cutting an estimated $1.21M.
  • NJ State Employees Deferred Compensation Plan fully exited CEC ENTERTAINMENT INC in Q1 2014, selling an estimated $1.11M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 16% of its $487M portfolio in Q1 2014.
  • NJ State Employees Deferred Compensation Plan opened 2 new positions and closed 46 in Q1 2014.
  • NJ State Employees Deferred Compensation Plan's portfolio value fell 0.76% quarter-over-quarter to $487M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2014, filed 5 May 2014.